Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas
about
CC chemokine ligand 18 correlates with malignant progression of prostate cancer.CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential.Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.Role of CCL18 in asthma and lung immunity.The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway.Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase 1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma.Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?Dissecting gene-environment interactions: A penalized robust approach accounting for hierarchical structures.Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.Clinical importance of chemokines and inflammatory cytokines for patient care following percutaneous nephrolithotripsy.CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
P2860
Q34114310-16CE11FD-87FC-4823-93A2-0D1536CF5217Q34562135-32DB8829-EFB8-43B6-94AF-C4C1E6F32171Q37086004-21049D55-34B9-49B0-A094-5BC7B0DB8500Q38115809-8B893691-BA94-47E7-B560-E559EB05AD8DQ38296670-0490279A-0F48-44C0-8A08-15481E2D6265Q38846374-9652BCC7-3FF0-404A-8A64-E99BDBEA570FQ41875277-D6C5A42A-162B-46D7-8753-B75727EC2742Q42366226-EC4E89C3-0E47-4309-A165-31EA8F1AE4E4Q47789970-A5B849A5-4933-4625-8230-2FE20D2636E1Q48572701-78A78EB8-DE05-44BD-86E8-EFB93A15791DQ50053870-3EFC117C-6BC6-4AC1-8388-688015196882Q53213076-75F3A0F1-3B11-469E-B87C-F323230BE092
P2860
Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas
description
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2012
@ast
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2012)
@en
vedecký článok (publikovaný 2012)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd in 2012)
@nl
наукова стаття, опублікована у 2012
@uk
name
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@ast
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@en
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@nl
type
label
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@ast
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@en
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@nl
prefLabel
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@ast
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@en
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@nl
P2093
P2860
P1433
P1476
Serum level of CC-chemokine li ...... rvival time in adenocarcinomas
@en
P2093
Alexander Krohn
Bernward Passlick
Joachim Müller-Quernheim
Meike Burger
Till Plönes
P2860
P304
P356
10.1371/JOURNAL.PONE.0041746
P407
P577
2012-07-25T00:00:00Z